This is the same pathway activated by naturally occurring GLP-1 released from your gut after eating
Cardiovascular Risk Markers TRIUMPH-4 also assessed a panel of cardiometabolic biomarkers, and the results were broadly favorable across the board: Non-HDL cholesterol significant reductions, indicating improved atherogenic lipid burden Triglycerides meaningful decreases, consistent with the known effects of GLP-1 and GIP receptor activation on lipid metabolism High-sensitivity C-reactive protein (hsCRP) substantial reductions, reflecting decreased systemic inflammation
Phase 3 TRIUMPH trials ongoing as of 2026
This suggests that the incretin system, which retatrutide mimics and amplifies, is naturally more active at certain times of day
Mild side effects may occur but typically subside
Over time, regular drinking alters metabolism, promotes visceral fat storage, and increases insulin resistance